Roee Holtzer1, Claudene J George2, Meltem Izzetoglu3, Cuiling Wang2. 1. Albert Einstein College of Medicine Bronx, New York, USA; Yeshiva University Bronx, New York, USA. Electronic address: roee.holtzer@einstein.yu.edu. 2. Albert Einstein College of Medicine Bronx, New York, USA. 3. Villanova University, Electrical and Computer Engineering, Villanova, PA, USA.
Abstract
BACKGROUND: Gait alterations were documented in diabetic patients. However, the effect of diabetes on cortical control of gait has not been reported. We evaluated the effect of diabetes on prefrontal cortex (PFC) Oxygenated Hemoglobin (HbO2) levels during active walking in older adults. METHODS: Of the total sample (n = 315; mean age = 76.84 ± 6.71ys; % female = 56.5) 43 participants (13.7%) had diabetes. The experimental paradigm consisted of two single tasks: Normal-Walk (NW); and Cognitive Interference (Alpha); and one dual-task condition consisting of the two single tasks, Walk-While-Talk (WWT). Functional Near-Infrared-Spectroscopy (fNIRS) was used to quantify PFC HbO2 levels. RESULTS: Older adults without diabetes showed higher PFC HbO2 levels in WWT compared to both NW and Alpha. HbO2 levels during NW were not different between the two groups. Consistent with Neural Inefficiency, older adults with diabetes exhibited higher HbO2 levels during Alpha while performing significantly worse than those without diabetes. Moreover, the presence of diabetes was associated with attenuated HbO2 levels during WWT. This pattern is consistent with Capacity Limitations suggesting a failure to recruit brain resources vis-à-vis the more cognitively challenging WWT condition. CONCLUSIONS: A distinct functional neural signature of diabetes was established during active and attention demanding walking among older adults without overt neurological disease.
BACKGROUND: Gait alterations were documented in diabeticpatients. However, the effect of diabetes on cortical control of gait has not been reported. We evaluated the effect of diabetes on prefrontal cortex (PFC) Oxygenated Hemoglobin (HbO2) levels during active walking in older adults. METHODS: Of the total sample (n = 315; mean age = 76.84 ± 6.71ys; % female = 56.5) 43 participants (13.7%) had diabetes. The experimental paradigm consisted of two single tasks: Normal-Walk (NW); and Cognitive Interference (Alpha); and one dual-task condition consisting of the two single tasks, Walk-While-Talk (WWT). Functional Near-Infrared-Spectroscopy (fNIRS) was used to quantify PFC HbO2 levels. RESULTS: Older adults without diabetes showed higher PFC HbO2 levels in WWT compared to both NW and Alpha. HbO2 levels during NW were not different between the two groups. Consistent with Neural Inefficiency, older adults with diabetes exhibited higher HbO2 levels during Alpha while performing significantly worse than those without diabetes. Moreover, the presence of diabetes was associated with attenuated HbO2 levels during WWT. This pattern is consistent with Capacity Limitations suggesting a failure to recruit brain resources vis-à-vis the more cognitively challenging WWT condition. CONCLUSIONS: A distinct functional neural signature of diabetes was established during active and attention demanding walking among older adults without overt neurological disease.
Authors: Joe Verghese; Jeannette Mahoney; Anne F Ambrose; Cuiling Wang; Roee Holtzer Journal: J Gerontol A Biol Sci Med Sci Date: 2010-07-19 Impact factor: 6.053
Authors: Manon Brundel; Martijn van den Heuvel; Jeroen de Bresser; L Jaap Kappelle; Geert Jan Biessels Journal: J Neurol Sci Date: 2010-12-15 Impact factor: 3.181
Authors: Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels Journal: Diabetes Care Date: 2010-03-18 Impact factor: 19.112
Authors: Ana Maksimovic; Rens Hanewinckel; Vincentius J A Verlinden; Symen Ligthart; Albert Hofman; Oscar H Franco; Pieter A van Doorn; Henning Tiemeier; Abbas Dehghan; M Arfan Ikram Journal: J Diabetes Complications Date: 2015-10-20 Impact factor: 2.852
Authors: K Allison Amick; Gargi Mahapatra; Jaclyn Bergstrom; Zhengrong Gao; Suzanne Craft; Thomas C Register; Carol A Shively; Anthony J A Molina Journal: Am J Physiol Endocrinol Metab Date: 2021-09-27 Impact factor: 4.310
Authors: Cristina Udina; Stella Avtzi; Turgut Durduran; Roee Holtzer; Andrea L Rosso; Carmina Castellano-Tejedor; Laura-Monica Perez; Luis Soto-Bagaria; Marco Inzitari Journal: Front Aging Neurosci Date: 2020-01-21 Impact factor: 5.750